l*a
2 楼
美式潙仰禪 將首次在紐約市介紹
傳承於大乘佛法潙仰宗的祖師禪，
永化法師因受美式教育的影響，
教禪指示明白直接，實際易懂，機用圓融。
世界各地學習美式潙仰禪的學生們，
迅速的看到自己的進步。
他們變得更有耐心及寬容，更有精神活力，
專注力增強，做事效率也自然而然提升。
https://youtu.be/7BwuAT0I6o8
Master YongHua is coming to New York in this October.
Chan meditation is the most advanced form of Mahayana Buddhist meditation.
Passed down directly from the Buddha through his lineage of Patriarchs to
the present, the power of Chan Meditation has been taught to seekers of
enlightenment in Asia for thousands of years.
“Chan Meditation Beyond Mindfulness” presents these ancient skills to the
West in an accessible, easy to follow format so we call it "American Chan".
From the basic stretches to the all-encompassing foundations of Buddhism,
Chan Master YongHua will reveal the extraordinary method of Chan Meditation,
which can benefit all people, regardless of their religious affiliation.
Wednesday, Oct 24, 2018, 12-1:20pm
WeWork Wall Street, in Downstairs Mailroom
Thursday, Oct 25, 2018, 5-6:20pm
WeWork Queens Plaza
Friday, Oct 26, 2018 5:30-6:50pm
WeWork NoMad
欲知詳請，報名網址：www.ChanPureLand.org/New-York
傳承於大乘佛法潙仰宗的祖師禪，
永化法師因受美式教育的影響，
教禪指示明白直接，實際易懂，機用圓融。
世界各地學習美式潙仰禪的學生們，
迅速的看到自己的進步。
他們變得更有耐心及寬容，更有精神活力，
專注力增強，做事效率也自然而然提升。
https://youtu.be/7BwuAT0I6o8
Master YongHua is coming to New York in this October.
Chan meditation is the most advanced form of Mahayana Buddhist meditation.
Passed down directly from the Buddha through his lineage of Patriarchs to
the present, the power of Chan Meditation has been taught to seekers of
enlightenment in Asia for thousands of years.
“Chan Meditation Beyond Mindfulness” presents these ancient skills to the
West in an accessible, easy to follow format so we call it "American Chan".
From the basic stretches to the all-encompassing foundations of Buddhism,
Chan Master YongHua will reveal the extraordinary method of Chan Meditation,
which can benefit all people, regardless of their religious affiliation.
Wednesday, Oct 24, 2018, 12-1:20pm
WeWork Wall Street, in Downstairs Mailroom
Thursday, Oct 25, 2018, 5-6:20pm
WeWork Queens Plaza
Friday, Oct 26, 2018 5:30-6:50pm
WeWork NoMad
欲知詳請，報名網址：www.ChanPureLand.org/New-York
l*1
3 楼
Iceberg Alert for NIH
>On 2 January 2013, budget sequestration
mandated by the Budget Control Act of 2011 could reduce NIH extramural
funds still further, producing a staggering cumulative 41% decline in a
single decade (in constant dollars, from 2004 to 2014
and
>In contrast, China’s governmental support for
biomedical research may double that of the United States, or even, in
proportion
to gross domestic product (GDP), quadruple it by 2017.*
In dollars.
Henry R. Bourne and Mark O. Lively
Henry R. Bourne is professor emeritus in the Department of Cellular and
Molecular Pharmacology at the University of California at San Francisco.
Email:
bourne {at} cmp.ucsf.edu.
Mark O. Lively is a professor in the Department of Biochemistry at the Wake
Forest School of Medicine, Winston-Salem, NC. E-mail:
mlively [at] wakehealth.edu.
A century ago, the unsinkable Titanic charged into a moonless night, full
steam ahead. Today, unless it changes course to escape its own icebergs, the
U.S. biomedical research enterprise hurtles toward a similar doom. The
fiscal year 2012 budget of the U.S. National Institutes of Health (NIH) buys
18% less research than in 2004. On 2 January 2013, budget sequestration
mandated by the Budget Control Act of 2011 could reduce NIH extramural
funds still further, producing a staggering cumulative 41% decline in a
single decade (in constant dollars, from 2004 to 2014), down to the level
that
NIH invested in 1997. In contrast, China’s governmental support for
biomedical research may double that of the United States, or even, in
proportion
to gross domestic product (GDP), quadruple it by 2017.*
In dollars, the contributions of NIH-supported research to human health,
jobs, and national economic growth far surpass investments budgeted by
Congress. The obvious inference: Investment in NIH should not shrink but
steadily increase, at a rate proportional to GDP. Instead, as grant dollars
shrink, institutions will be forced to curtail biomedical research
drastically, mimicking the recent layoff of 150 research faculty and
hundreds of other
employees by the University of Miami’s Miller School of Medicine.
Established researchers at rich institutions may survive, but many in the
rising
generation of young investigators and in small research programs will drown.
Institutions will further trim hard-money contributions to faculty salaries
and find it even harder to pay for and populate research facilities they
recently expanded. Competition for faculty positions, grants, and published
papers will grow ever fiercer. And the postdoctoral holding tank will brim
over, as myriad well-trained young scientists vainly seek research jobs.
Apparently unaware that the model for funding U.S. biomedical research is
close to collapse, key stakeholders in the biomedical research community,
like mythical Titanic passengers, busy themselves rearranging deck chairs.
We urge those stakeholders—faculty, academic administrators,
funding agency leaders, and (if it can) Congress itself—to unite to plot a
dramatically different course. Radical actions are called for that
distribute
scarce resources more efficiently, with a focus on helping the best young
and established scientists survive the present storm for as long as it lasts,
even if it means a substantial decrease in the size of their research groups.
Research institutions must discard their present corporate business model,
which is based on the assumption that federal funds to support research
programs will increase every year. Those institutions must invest more in
direct salary support for faculty scientists and less in bricks and mortar.
NIH should require institutions to pay a larger share of principal
investigators’ salaries (in increments, spread over time), and indirect
cost rules that
currently encourage universities to build labs rather than nourish their own
faculty must be changed.† Even more broadly, faculty, administrators,
research institutions, and NIH must work together to tackle knotty problems
of resource distribution, as we describe in the supplement.
Academic labs today depend on graduate students and postdocs to supply the
workforce that keeps them humming. This dependence, which generates
multiple potential competitors for soft-money positions and grants but does
not always train young scientists effectively, must be reduced by
implementing and further strengthening the recommendations of a just-
released report from NIH’s Biomedical Research Workforce Working
Group.‡
To devise effective local and national responses to the impending crisis,
new strategies must be implemented quickly. The status quo is untenable,
and the alternatives are dire: Failure to adjust to the new reality means
that stakeholders may be forced to scrounge seats in a lifeboat, or—like
the majority of Titanic passengers—drown.
*See supplementary materials at sofa floor
>On 2 January 2013, budget sequestration
mandated by the Budget Control Act of 2011 could reduce NIH extramural
funds still further, producing a staggering cumulative 41% decline in a
single decade (in constant dollars, from 2004 to 2014
and
>In contrast, China’s governmental support for
biomedical research may double that of the United States, or even, in
proportion
to gross domestic product (GDP), quadruple it by 2017.*
In dollars.
Henry R. Bourne and Mark O. Lively
Henry R. Bourne is professor emeritus in the Department of Cellular and
Molecular Pharmacology at the University of California at San Francisco.
Email:
bourne {at} cmp.ucsf.edu.
Mark O. Lively is a professor in the Department of Biochemistry at the Wake
Forest School of Medicine, Winston-Salem, NC. E-mail:
mlively [at] wakehealth.edu.
A century ago, the unsinkable Titanic charged into a moonless night, full
steam ahead. Today, unless it changes course to escape its own icebergs, the
U.S. biomedical research enterprise hurtles toward a similar doom. The
fiscal year 2012 budget of the U.S. National Institutes of Health (NIH) buys
18% less research than in 2004. On 2 January 2013, budget sequestration
mandated by the Budget Control Act of 2011 could reduce NIH extramural
funds still further, producing a staggering cumulative 41% decline in a
single decade (in constant dollars, from 2004 to 2014), down to the level
that
NIH invested in 1997. In contrast, China’s governmental support for
biomedical research may double that of the United States, or even, in
proportion
to gross domestic product (GDP), quadruple it by 2017.*
In dollars, the contributions of NIH-supported research to human health,
jobs, and national economic growth far surpass investments budgeted by
Congress. The obvious inference: Investment in NIH should not shrink but
steadily increase, at a rate proportional to GDP. Instead, as grant dollars
shrink, institutions will be forced to curtail biomedical research
drastically, mimicking the recent layoff of 150 research faculty and
hundreds of other
employees by the University of Miami’s Miller School of Medicine.
Established researchers at rich institutions may survive, but many in the
rising
generation of young investigators and in small research programs will drown.
Institutions will further trim hard-money contributions to faculty salaries
and find it even harder to pay for and populate research facilities they
recently expanded. Competition for faculty positions, grants, and published
papers will grow ever fiercer. And the postdoctoral holding tank will brim
over, as myriad well-trained young scientists vainly seek research jobs.
Apparently unaware that the model for funding U.S. biomedical research is
close to collapse, key stakeholders in the biomedical research community,
like mythical Titanic passengers, busy themselves rearranging deck chairs.
We urge those stakeholders—faculty, academic administrators,
funding agency leaders, and (if it can) Congress itself—to unite to plot a
dramatically different course. Radical actions are called for that
distribute
scarce resources more efficiently, with a focus on helping the best young
and established scientists survive the present storm for as long as it lasts,
even if it means a substantial decrease in the size of their research groups.
Research institutions must discard their present corporate business model,
which is based on the assumption that federal funds to support research
programs will increase every year. Those institutions must invest more in
direct salary support for faculty scientists and less in bricks and mortar.
NIH should require institutions to pay a larger share of principal
investigators’ salaries (in increments, spread over time), and indirect
cost rules that
currently encourage universities to build labs rather than nourish their own
faculty must be changed.† Even more broadly, faculty, administrators,
research institutions, and NIH must work together to tackle knotty problems
of resource distribution, as we describe in the supplement.
Academic labs today depend on graduate students and postdocs to supply the
workforce that keeps them humming. This dependence, which generates
multiple potential competitors for soft-money positions and grants but does
not always train young scientists effectively, must be reduced by
implementing and further strengthening the recommendations of a just-
released report from NIH’s Biomedical Research Workforce Working
Group.‡
To devise effective local and national responses to the impending crisis,
new strategies must be implemented quickly. The status quo is untenable,
and the alternatives are dire: Failure to adjust to the new reality means
that stakeholders may be forced to scrounge seats in a lifeboat, or—like
the majority of Titanic passengers—drown.
*See supplementary materials at sofa floor
l*1
4 楼
continue:
link:
//www.sciencemag.org/content/early/2012/07/03/science.1226460
or
free down full text:
//www.scribd.com/doc/99548158/Iceberg-Alert-for-NIH
and
Bio/Medi PhD awarded total amount within States should be rentruned
to 1996 to 1998 level from 2016 and with 购买力平价 指标和指数
具体看图说话
pdf link:
//www.scribd.com/doc/99548376/Iceberg-Alert-for-NIH-supplement
link:
//www.sciencemag.org/content/early/2012/07/03/science.1226460
or
free down full text:
//www.scribd.com/doc/99548158/Iceberg-Alert-for-NIH
and
Bio/Medi PhD awarded total amount within States should be rentruned
to 1996 to 1998 level from 2016 and with 购买力平价 指标和指数
具体看图说话
pdf link:
//www.scribd.com/doc/99548376/Iceberg-Alert-for-NIH-supplement
l*1
5 楼
看来R01 PIs 要开始猛补 mandarin language skill 了 哈
相关阅读
关于干细胞研究用WGS寻找疾病structural variation的文章如何在两个城市之间邮寄培养中的human T cells求高人指点：是留在学校继续千老还是进小公司？ (转载)各位大牛，MDCK cell 转染用什么比较好？各位，找药厂或生物公司的职位都上哪找？Circos真是我用过的最难用的工具生物人不要再把别人眼里微不足道的东西当个宝了E.coli及其感受态细胞在-45C下长期保存好不好？HPV疫苗真的有用吗？paper thanksCaspase 3 activating Caspase 8 or 9?庆红走好有做IVD的前辈吗？请教 regulation and standards affect IVD一个简单的生物学实验问题paper help美国华人生物医学发考题猝死现象postdoc口头offer多久以后会有正式的offerplagiarism checker制药公司招生物信息Senior Information Scientist